Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of?>?80,000 patients (the SGLT2i—Arrhythmias and Sudden Cardiac Death)
Cardiovascular Diabetology
FEBRUARY 23, 2024
Objective We aimed to assess the effect of SGLT2i on arrhythmias by conducting a meta-analysis using data from randomized controlled trials(RCTs). Background Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have shown cardioprotective effects via multiple mechanisms that may also contribute to decrease arrhythmias risk.
Let's personalize your content